Under the umbrella of CANet, more than 100 investigators across Canada conduct research under three broad themes.
Programs and projects cut across themes, bringing multi-sectoral and multidisciplinary perspectives to bear on these challenges.
Research partners include clinicians, biomedical and other researchers, engineers, patients, and industry and government partners. The network takes advantage of advances in computing power, internet-based communication, and accessible data to improve care.
CANet provides the biotech industry with opportunities to develop, test and market new technologies and therapies for the diagnosis and treatment of arrhythmias.
Research output from the Network has a significant impact on health and wealth creation in Canada.
A transformed Canadian arrhythmia care system that delivers personalized, patient-driven, integrated care resulting in improved access, quality, effectiveness and efficiency of care.
By delivering the best care to the patient at the right time and in the right environment, VIRTUES will result in the most efficient and effective care for each arrhythmia patient. Furthermore, once developed, the VIRTUES data platform will strategically enrich high-quality research directed at further improving outcomes of arrhythmia care.
Combining wearable biosensor technology (providing personalized physiological data), digital multi-media interfaces (providing personalized demographic structured and unstructured data) and validated analytics, VIRTUES will immediately integrate symptom-driven validated physiological data (rhythm, BP, others) into a patient-specific, personalized context and trigger an appropriate care plan from a set of plan previously co-developed with the patient. Read more about VIRTUES in the 2016-2019 Strategic Plan.
A state-of-the-art informatics platform that partners advanced analytics with data storage, federation and management.
Heart-SIGN will be an informatics platform that manages the acquisition, integration, storage, federation, analysis and sharing of multidimensional data collected from CANet study patients.
Heart-SIGN will not only be the data resource for arrhythmia research and clinical practice but also will provide a platform for research-based and clinical initiatives to identify clinical needs, track patients through the medical care system, and to measure outcomes. This unprecedented level of information and analytical capability will inform changes processes leading to system and patient level advances in treatment. Read more about Heart-SIGN in the 2016-2019 Strategic Plan.